|
School of Medicine Program Features Latest Findings on Fragile X Syndrome
ATLANTA - Geneticists at Emory University School of Medicine, who lead
the world’s largest research program on fragile X syndrome, will present
their latest research findings and expectations for future treatments
at an event at Emory on Thursday, Sept. 18, from 5:00 p.m. to 7:30 p.m.
The program, called "Building for the Future," is free and open to the
public, and will be held in the Whitehead Biomedical Research Building
on the Emory University campus.
The program is sponsored by event chairs Mr. and Mrs. Lyons Heyman,
Jr. and Mr. and Mrs. Rick Reynolds, and includes the following schedule:
Opening Reception
5:00 p.m.
Presentations
5:30 p.m.
Tour of Department of Human Genetics
6:15 p.m.
Closing Reception
6:45 p.m.
The presentations will include a history of research on fragile X syndrome
at Emory, including the discovery by the Emory team of the gene responsible
for fragile X -- FMR1. The program also includes an overview of all
ongoing areas of fragile X research at Emory, including characterization
of the genetic precursors to fragile X, newborn and population screening,
the mechanisms of cognitive problems in fragile X, and potential new
approaches to treatment. Visitors will be able to tour the fragile X
laboratories, including demonstrations of some of the most advanced
instrumentation in Georgia, being used in the research efforts for fragile
X syndrome.
If you would like to attend the program, please reply on or before September
10 to Lauren Koontz at 404-727-4085 or email lkoontz@genetics.emory.edu.
|
